Targeted Release Formulation (TRF) Budesonide (Nefecon) Reduces Serum Biomarkers of Lymphocyte Activation in IgA Nephropathy, Which Correlates with Changes in Serum B Cell-Activating Factor (BAFF) Levels
Budesonide (Nefecon)
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Targeted Release Formulation (TRF) Budesonide (Nefecon) Reduces Serum Biomarkers of Lymphocyte Activation in IgA Nephropathy, Which Correlates with Changes in Serum B Cell-Activating Factor (BAFF) Levels ### Output: Budesonide (Nefecon)